ANUH PHARMA
Back to Income Statement
|
ANUH PHARMA Last 5 Year Revenue History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹662 Cr | ₹647 Cr | ₹527 Cr | ₹487 Cr | ₹432 Cr |
What is the latest Revenue of ANUH PHARMA ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹662 Cr |
| Mar2024 | ₹647 Cr |
| Mar2023 | ₹527 Cr |
| Mar2022 | ₹487 Cr |
| Mar2021 | ₹432 Cr |
How is Revenue of ANUH PHARMA Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹662 Cr | 2.24 | |
| Mar2024 | ₹647 Cr | 22.66 | |
| Mar2023 | ₹527 Cr | 8.39 | |
| Mar2022 | ₹487 Cr | 12.66 | |
| Mar2021 | ₹432 Cr | - | |
Compare Revenue of peers of ANUH PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ANUH PHARMA | ₹794.7 Cr | -0.7% | -2.7% | -27.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,170.0 Cr | -1.6% | 4.6% | -0.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,038.0 Cr | -2.5% | -6% | 3.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹127,357.0 Cr | 1.2% | -1.4% | 11.8% | Stock Analytics | |
| CIPLA | ₹120,414.0 Cr | -1.2% | -1.5% | -0.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,015.0 Cr | -2.7% | 4% | 2.2% | Stock Analytics | |
ANUH PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ANUH PHARMA | -0.7% |
-2.7% |
-27.2% |
| SENSEX | -0.6% |
1.7% |
4.6% |
You may also like the below Video Courses